Vaso Corp (VASO) — SEC Filings
Vaso Corp (VASO) — 18 SEC filings. Latest: 8-K (Dec 19, 2025). Includes 7 8-K, 6 10-Q, 2 DEF 14A.
Overview
Vaso Corp (VASO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 19, 2025: VASO Corp filed an 8-K on December 19, 2025, reporting on matters submitted to a vote of security holders and financial statements as of December 17, 2025. The company, formerly known as Vasomedical, Inc., is incorporated in Delaware and operates in the electromedical apparatus sector.
Sentiment Summary
Across 18 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 15 neutral, 1 mixed. The dominant filing sentiment for Vaso Corp is neutral.
Filing Type Overview
Vaso Corp (VASO) has filed 7 8-K, 1 DEFA14A, 6 10-Q, 2 DEF 14A, 2 10-K with the SEC between Apr 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (18)
Risk Profile
Risk Assessment: Of VASO's 15 recent filings, 1 were flagged as high-risk, 4 as medium-risk, and 10 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $22.657M |
| Net Income | $1.711M |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $34.859M |
| Operating Margin | N/A |
| Total Assets | $84.474M |
| Total Debt | N/A |
Key Executives
- Joshua Markowitz
- Jun Ma, PhD
- Jonathan Newton
- Behnam Movaseghi
- Jane Moen
- Leon Dembo
Industry Context
VASO Corp operates in the IT services and sales solutions sector. The industry is characterized by rapid technological advancements and evolving client needs, requiring continuous adaptation. Competition is often driven by service quality, specialized expertise, and pricing. The shift towards managed IT services and specialized sales support reflects a broader trend of companies outsourcing complex functions to focus on core competencies.
Top Tags
10-Q (4) · financials (4) · corporate-governance (3) · quarterly-report (3) · 8-K (2) · Healthcare IT (2) · Medical Devices (2) · 10-K (2) · filing (2) · VASO Corp (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net income for Q3 2025 | $1.711M | Reversed a net loss of $1.181 million in Q3 2024. |
| Total revenues for Q3 2025 | $22.657M | Increased by 9.09% from $20.769 million in Q3 2024. |
| Professional sales services revenue for Q3 2025 | $10.820M | Increased by 18.72% from $9.114 million in Q3 2024. |
| Net income for nine months ended Sept 30, 2025 | $0.439M | Reversed a net loss of $1.199 million in the prior year period. |
| Total revenues for nine months ended Sept 30, 2025 | $62.076M | Increased by 3.92% from $59.732 million in the prior year period. |
| Operating income for Q3 2025 | $1.538M | Improved from an operating loss of $1.393 million in Q3 2024. |
| Cash and cash equivalents as of Sept 30, 2025 | $34.859M | Increased from $26.271 million at Dec 31, 2024. |
| Net cash provided by operating activities for nine months ended Sept 30, 2025 | $9.012M | Increased from $3.648 million in the prior year period. |
| Accumulated deficit as of Sept 30, 2025 | $33.642M | Reduced from $34.081 million at Dec 31, 2024, but still significant. |
| Shares Outstanding | 175,953,035 | As of November 10, 2025. |
| Shares of common stock outstanding | 175,953,035 | As of October 31, 2025, entitled to vote |
| Voting power of officers and directors as a group | 43.85% | Indicates significant insider control over voting matters |
| Beneficial ownership of Joshua Markowitz | 31.88% | Largest individual shareholder and director |
| Number of Class II directors to be elected | 3 | Serving a three-year term until the 2028 annual meeting |
| Date of Annual Meeting | December 17, 2025 | When key proposals will be voted on |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Vaso Corp (VASO)?
Vaso Corp has 18 recent SEC filings from Apr 2024 to Dec 2025, including 7 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of VASO filings?
Across 18 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 15 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Vaso Corp SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Vaso Corp (VASO) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Vaso Corp?
Key financial highlights from Vaso Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for VASO?
The investment thesis for VASO includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Vaso Corp?
Key executives identified across Vaso Corp's filings include Joshua Markowitz, Jun Ma, PhD, Jonathan Newton, Behnam Movaseghi, Jane Moen and 1 others.
What are the main risk factors for Vaso Corp stock?
Of VASO's 15 assessed filings, 1 were flagged high-risk, 4 medium-risk, and 10 low-risk.
What are recent predictions and forward guidance from Vaso Corp?
Forward guidance and predictions for Vaso Corp are extracted from SEC filings as they are enriched.